Saintphareux

The project operates in a highly relevant and impactful field (AI-driven medical sensing and early disease detection), and its company description suggests a sophisticated technical foundation. However, the submission itself is extremely poor and features highly exaggerated, unsupported claims—such as stating 'everyone' is the audience and 'most people have used my product' despite a 2024 launch date. The lack of credible, verifiable traction metrics and unrealistic responses significantly compromise the submission's integrity, resulting in a low Proof of Usefulness score.